Literature DB >> 9534102

Compliance, electronic monitoring and antihypertensive drugs.

J M Mallion1, J P Baguet, J P Siche, F Tremel, R de Gaudemaris.   

Abstract

Hypertension, even of mild-to-moderate severity, is undoubtedly a risk factor for cardiovascular morbidity and mortality. It has been well demonstrated, in numerous studies that have been subjected to meta-analysis, that the introduction of antihypertensive treatment leads to reductions in cardiovascular and cerebrovascular events. These results can be obtained with even a moderate reduction in blood pressure, of the order of 4-5 mmHg in diastolic blood pressure. However, many studies have shown that the percentage of treated hypertensive individuals who have a reduction in blood pressure to normal values of systolic blood pressure/ diastolic blood pressure (< 140/90 mmHg) is of the order of 30%. The reduction in blood pressure data are well correlated with the level of compliance. This compliance can be defined as the adherence by the patient to the directions given by the doctor for medication dosage, and this can be considered as 'good' when it is of the order of 80%. Until recently the examination of compliance relied on questioning the patient, pill counts or ultimately blood sampling for drug levels, which could be used only in research. The use of an electronic pill box with a microprocessor in the cover that records the date and hour each time the box is opened is a precise method of recording compliance. The purpose of such a method is to study overall compliance, which deteriorates as time passes and falls by approximately 50% after 1 year. However, this compliance can be modified and improved if instruction and follow-up are given to the patient. Prescription compliance can be improved by once daily dosing and by instructing for this to be taken in the morning. In contrast compliance is considerably reduced when more than two doses are to be taken each day. Using the pill counting box allows us to describe and focus on different types of patients, ranging from rigidly adherent to completely chaotic. It seems that factors such as age and activity can influence these patterns of compliance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534102

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  13 in total

1.  Behavior-changing methods for improving adherence to medication.

Authors:  C Willey
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

2.  Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study.

Authors:  Maribel Salas; Catarina I Kiefe; Pamela J Schreiner; Yongin Kim; Lucia Juarez; Sharina D Person; O Dale Williams
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

Review 3.  Medication adherence in heart failure.

Authors:  Paul J Hauptman
Journal:  Heart Fail Rev       Date:  2007-05-04       Impact factor: 4.214

Review 4.  Medication adherence: a call for action.

Authors:  Hayden B Bosworth; Bradi B Granger; Phil Mendys; Ralph Brindis; Rebecca Burkholder; Susan M Czajkowski; Jodi G Daniel; Inger Ekman; Michael Ho; Mimi Johnson; Stephen E Kimmel; Larry Z Liu; John Musaus; William H Shrank; Elizabeth Whalley Buono; Karen Weiss; Christopher B Granger
Journal:  Am Heart J       Date:  2011-09       Impact factor: 4.749

5.  Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study.

Authors:  R Nuesch; K Schroeder; T Dieterle; B Martina; E Battegay
Journal:  BMJ       Date:  2001-07-21

6.  Recommendations for Providers on Person-Centered Approaches to Assess and Improve Medication Adherence.

Authors:  Hayden B Bosworth; Stephen P Fortmann; Jennifer Kuntz; Leah L Zullig; Phil Mendys; Monika Safford; Shobha Phansalkar; Tracy Wang; Maureen H Rumptz
Journal:  J Gen Intern Med       Date:  2017-01       Impact factor: 5.128

7.  Polarization sensing of fluorophores in tissues for drug compliance monitoring.

Authors:  Z Gryczynski; O O Abugo; J R Lakowicz
Journal:  Anal Biochem       Date:  1999-09-10       Impact factor: 3.365

8.  Compliance with therapy in hypertensive patients.

Authors:  Alfonso Lagi; Antonio Rossi; Maria Teresa Passaleva; Alessandro Cartei; Simone Cencetti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 9.  Medication non-adherence in the elderly: how big is the problem?

Authors:  Carmel M Hughes
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 10.  Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.

Authors:  Thomas Unger; Elena Kaschina
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.